FDA Approves Dawnzera (donidaloirsen)

Aug 21, 2025

Dawnzera (donidaloirsen) is the first and only RNA-targeted prophylactic treatment for hereditary angioedema. This placeholder page can be updated with full content later.

← Back to Home
DermaRite Recall - PharmaOnline
Register

DermaRite Industries Issues Recall

DermaRite Industries Issues Recall of DermaKleen, Dermasarra, Kleenfoam, and Perigiene Products Due to Burkholderia cepacia Contamination

Insert the full article content here. You can get this from FDA Medwatch Alerts